[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100413922":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":45,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"University of Miami","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"endotoxin study group",null,"Patients scheduled for Percutaneous Nephrolithotomy (PCNL) as surgical treatment for their kidney stones will be evaluated for postoperative endotoxin levels as a risk marker for sepsis.",[13],{"name":14,"affiliation":5,"role":15},"Hemendra N Shah","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","3052433246","hns35@miami.edu",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Miami","Florida","33136","United States","US",{"type":30,"coordinates":31},"Point",[32,33],-80.19366,25.77427,{"lat":33,"lon":32},[36,39,42,43],{"name":37,"role":18,"phone":38,"phoneExt":10,"email":20},"Hemendra N Shah, MD","305-243-3246",{"name":10,"role":18,"phone":10,"phoneExt":40,"email":41},"shah","drhemendrashah@yahoo.co.in",{"name":37,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":44,"role":15,"phone":10,"phoneExt":10,"email":10},"Robert Marcovich, MD",{"type":15,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Hemendra Shah","Associate Professor of clinical Urology","100413922","serum-endotoxin-assay-to-predict-the-development-of-postoperative-infectious-complications-and-systemic-inflammatory-response-following-percutaneous-nephrolithotomy-100413922",false,"NCT04669886","Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.","Inclusion Criteria:\n\n* Adults that is able to consent (≥ 18 years of age)\n* Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals\n* not currently immunosuppressed \\[White blood count (WBC) \\>= 2, not on immunosuppressive medications\\]\n\nExclusion Criteria:\n\n* unable to consent and \\\u003C 18 years of age\n* currently immunosuppressed (WBC \\\u003C 2, not on immunosuppressive medications)","ALL","18 Years",{"count":57,"type":58},150,"ESTIMATED","OBSERVATIONAL","The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.",[62,63],"Nephrolithiasis","Urosepsis",[65,66,67,68,69],"endotoxin","fever","infectious complications","endourology","percutaneous nephrolithotomy","2025-09-01",{"date":72,"type":73},"2025-09-03","ACTUAL",{"date":75,"type":73},"2023-11-01",{"date":77,"type":58},"2026-12-01",{"name":5,"class":6},1]